OncoMatch/Clinical Trials/NCT07863258
STRATHEP: AI-Driven Treatment Stratification for Advanced Hepatocellular Carcinoma
Official title: Treatment STRATification in Patients With Advanced HEPatocellular Carcinoma (STRATHEP)
Is NCT07863258 recruiting? Yes, currently enrolling (Oct 2026).
STRATHEP develops and validates a multimodal AI model to predict treatment response in advanced hepatocellular carcinoma. By integrating digital pathology and MRI radiomics, the project identifies patients likely to benefit from modern systemic therapies, using the RECIST 1.1 framework as the primary benchmark.
Check if I qualifyExtracted eligibility criteria
Cancer type
Hepatocellular Carcinoma
Prior therapy
Must have received: systemic therapy
Hepatocellular carcinoma treated with systemic treatment during the disease course
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07863258 currently recruiting?
Yes, this trial is currently recruiting patients.
Is prior treatment required for enrollment?
Yes. Patients must have previously received systemic therapy.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages